Chargement en cours...
Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications
PURPOSE: The number of targeted oral anticancer medications (TOAMs) has grown rapidly in the past decade. The high cost of TOAMs raises concerns about the financial aspect of treatment, especially for patients enrolled in Medicare Part D plans because of the coverage gap. METHODS: We identified pati...
Enregistré dans:
| Publié dans: | J Oncol Pract |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Clinical Oncology
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366250/ https://ncbi.nlm.nih.gov/pubmed/28095170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2016.014639 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|